| Literature DB >> 32443899 |
Maurizio Cecconi1,2, Daniele Piovani1,2, Enrico Brunetta1,2, Alessio Aghemo1,2, Massimiliano Greco1,2, Michele Ciccarelli1,2, Claudio Angelini1,2, Antonio Voza1,2, Paolo Omodei1,2, Edoardo Vespa1,2, Nicola Pugliese1,2, Tommaso Lorenzo Parigi1,2, Marco Folci1,2, Silvio Danese1,2, Stefanos Bonovas1,2.
Abstract
We described features of hospitalized Covid-19 patients and identified predictors of clinical deterioration. We included patients consecutively admitted at Humanitas Research Hospital (Rozzano, Milan, Italy); retrospectively extracted demographic; clinical; laboratory and imaging findings at admission; used survival methods to identify factors associated with clinical deterioration (defined as intensive care unit (ICU) transfer or death), and developed a prognostic index. Overall; we analyzed 239 patients (29.3% females) with a mean age of 63.9 (standard deviation [SD]; 14.0) years. Clinical deterioration occurred in 70 patients (29.3%), including 41 (17.2%) ICU transfers and 36 (15.1%) deaths. The most common symptoms and signs at admission were cough (77.8%) and elevated respiratory rate (34.1%), while 66.5% of patients had at least one coexisting medical condition. Imaging frequently revealed ground-glass opacity (68.9%) and consolidation (23.8%). Age; increased respiratory rate; abnormal blood gas parameters and imaging findings; coexisting coronary heart disease; leukocytosis; lymphocytopenia; and several laboratory parameters (elevated procalcitonin; interleukin-6; serum ferritin; C-reactive protein; aspartate aminotransferase; lactate dehydrogenase; creatinine; fibrinogen; troponin-I; and D-dimer) were significant predictors of clinical deterioration. We suggested a prognostic index to assist risk-stratification (C-statistic; 0.845; 95% CI; 0.802‒0.887). These results could aid early identification and management of patients at risk, who should therefore receive additional monitoring and aggressive supportive care.Entities:
Keywords: 2019 novel coronavirus; 2019-nCoV; COVID-19; SARS-CoV-2; severe acute respiratory syndrome coronavirus 2
Year: 2020 PMID: 32443899 DOI: 10.3390/jcm9051548
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241